All In Biotech

Drug Trial Radar · NCT07219771

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Oct 14, 2025

Primary completion

Jun 30, 2027

Study completion Dec 30, 2027

Sponsor

Lead sponsor
Doron Therapeutics Inc.Industry
Sponsor type
Industry
Collaborators
Novotech (Australia) Pty Limited
First posted
Oct 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, prospective, randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of intra-articular administration of PTP-001 (MOTYS) for the treatment of knee osteoarthritis. The purpose of the trial is to evaluate the efficacy, safety, and tolerability of a single intra-articular injection of PTP-001 compared to placebo over a 52-week period in participants with radiographic and symptomatic knee OA.

Conditions

  • Knee Osteoarthritis

Interventions

  • PTP-01Biological

    Allogeneic human placental tissue particulate (PTP-001) is administered as a single intra-articular injection to the target knee after resuspension with saline.

  • Placebo control / saline vehicleOther

    The placebo control, physiological saline (0.9% sodium chloride injection, USP), is administered as an intra-articular injection to the target knee.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants meeting strict responder criteria for improvement in knee function.Time frame: 6 months
  2. Proportion of participants meeting strict responder criteria for improvement in knee pain.Time frame: 6 months

Locations

18 sites in 2 countries. Site status is shown where the registry gives one.

  • Central Research Associates, LLC dba Flourish Research

    Birmingham, Alabama · Recruiting

  • Tucson Orthopaedic Institute

    Tucson, Arizona · Recruiting

  • Horizon Clinical Research

    La Mesa, California · Recruiting

  • Focus Clinical Research

    West Hills, California · Recruiting

  • Conquest Research, LLC

    Winter Park, Florida · Recruiting

  • Chicago Clinical Research Institute, Inc.

    Chicago, Illinois · Recruiting

  • Lehigh Center for Clinical Research

    Allentown, Pennsylvania · Withdrawn

  • Coastal Carolina Research Center, LLD

    North Charleston, South Carolina · Recruiting

  • JBR Clinical Research, LLC

    Salt Lake City, Utah · Recruiting

  • Emeritus Research Sydney

    Botany, New South Wales, Australia · Terminated

  • Genesis Research Services

    Broadmeadow, New South Wales, Australia · Recruiting

  • Royal North Shore Hospital

    St Leonards, New South Wales, Australia · Active not recruiting

  • University of the Sunshine Coast Clinical Trials, Birtinya

    Birtinya, Queensland, Australia · Active not recruiting

  • University of the Sunshine Coast Clinical Trials, Maroochydore

    Maroochydore, Queensland, Australia · Recruiting

  • University of the Sunshine Coast Clinical Trials, Morayfield

    Morayfield, Queensland, Australia · Active not recruiting

  • Momentum Clinical Research Taringa

    Taringa, Queensland, Australia · Active not recruiting

  • Momentum Clinical Research Wellers Hill

    Tarragindi, Queensland, Australia · Terminated

  • Momentum Clinical Research Sunshine

    St Albans, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.